Staphylococcus aureus represents one of the most met germs, with Escherichia coli, during bacteremia. Microbiologist distinguish at aureus S. two profiles of resistance in beta-lactamines: S. aureus sensitive to the methicillin ( SASM) and the S. aureus resistant to the methicillin ( SARM). With the implementation of the MALDI-TOF, it is now possible to identify the origin responsible of the bacteremia the day of the positivity of the hemoculture ( J0) and to set up a treatment with adapted antibiotic, which, in the case of a sepsis to aureus S., is the vancomycine. Ye it was demonstrated, that the use of the vancomycine on the SASM increased the average duration of stay and a more important rate of relapse. The PCR SARM was organized in the GHPSJ in 2014. It allows from the day of the positivity of the hemoculture ( J0), to determine the phenotype of resistance of S. aureus.
Study Type
OBSERVATIONAL
Enrollment
50
Polymerase Chain Reaction of Methicillin Resistant Staphyloccus Aureus
Groupe Hospitalier Paris Saint Joseph
Paris, Île-de-France Region, France
Adaptation duration of antibiotherapy
Time frame: 24 hours
Mortality
Time frame: Day 30
average duration of hospitalization
Time frame: day 30
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.